Introduction
============

There is increasing awareness amongst veterinarians of the significance of pain and the importance of analgesic therapies. The International Association for the Study of Pain has provided a definition of pain as an \"unpleasant sensory or emotional experience associated with actual or potential tissue damage or described in terms of such damage and has noted that the inability to communicate in no way negates the possibility that an individual is experiencing pain or is in need of appropriate pain-relieving treatment\" \[[@B32]\]. This definition has been adopted by the veterinary profession \[[@B39]\].

A survey carried out in 1999 of the attitudes of British veterinarians to perioperative analgesia in dogs found that whilst over 90% of respondents acknowledged that surgical castration involved pain, only 30% were likely to administer any analgesic agent \[[@B3]\]. The apparent low use of analgesic agents, despite acceptance that pain occurs in animals, has been ascribed to inability of animals to communicate that they are in pain, the lack of objective and validated methods to assess pain, fear of side effects from analgesic agents used to control pain and lack of knowledge of and/or appropriate use of analgesic drugs \[[@B3]\].

Analgesic therapy centres on the use of drugs, which modulate parts of the pain pathway. Treatment of preoperative pain is likely to be more successful if multimodal or pre-emptive analgesic strategies are employed. Multimodal analgesia is the use of combinations of drugs to provide analgesia. With each drug acting additively or synergistically, reduction of the dose of each drug used and consequently adverse effects associated with each drug is possible \[[@B25],[@B43]\]. Pre-emptive analgesia is the administration of analgesic agents before peripheral nociception begins, in an attempt to reduce postoperative hypersensitivity to pain \[[@B56],[@B5]\]. After hypersensitisation develops, pain can occur in the absence of stimulus or in response to innocuous stimuli, termed allodynia, or can lead to an exaggerated response to noxious stimuli, termed hyperalgesia \[[@B10]\]. The efficacy of pre-emptive analgesia in animals has been demonstrated in experimental rats \[[@B5]\] and in dogs \[[@B29]\]. True preemptive analgesia was not possible in this patient since painful stimuli were present prior to surgery.

This case report considers the perioperative pain management of a dog with a tumour of the brachial plexus undergoing thoracic limb amputation. In this patient in particular, considered analgesic management was essential for several reasons. Firstly, the patient was believed to be in pain, since it was aggressive when the tumour was handled and was difficult to restrain. Secondly, since the pain was chronic in duration, peripheral and central hypersensitisation was likely to be present, which can result in an increased requirement for analgesic agents to manage the pain or can lead to resistance to analgesic agents already used \[[@B43]\]. Thirdly, limb amputation in humans often causes \'phantom limb\' pain which usually replicates the pre-amputation pain, particularly where there has been no pain-free interval before surgery or where the pre-amputation pain was intense or chronic \[[@B23],[@B5],[@B43]\]. Our aim for this patient was to minimise psychological and physiological stress, to promote a rapid return to normal activity and to produce a balanced anaesthetic protocol using multimodal analgesia.

Case Report
===========

History and clinical examination
--------------------------------

An eight-year-old male entire Springer Spaniel, weighing 23 kg, was presented with a two-month history of chronic, progressive right thoracic limb lameness. There was no history of trauma or pyrexia. On clinical examination, the patient was tachycardic (140 beats/minute) and panting, but normothermic. Examination revealed marked right thoracic limb lameness with severe spinatus muscle atrophy and proprioceptive deficits. A strong pain response was elicited on palpation of a firm, fixed, 5 cm × 3 cm subcutaneous mass present in the right axilla. Based on the history and clinical examination, a tentative diagnosis of brachial plexus neoplasia was made; a schwannoma or neurilemmoma was suspected.

Preoperative findings
---------------------

Haematological and biochemical values were within reference limits. The day before surgery the patient was sedated using 5 μg kg^-1^medetomidine and 0.1 mg kg^-1^morphine administered by intramuscular (IM) injection to allow diagnostic imaging. Right and left lateral and dorsoventral thoracic radiographs were unremarkable. Ultrasonographic examination of the mass revealed an intramuscular encapsulated and locally invasive mass which was infiltrating the brachial plexus. Cytological examination of fine needle aspirates from the mass appeared non-diagnostic.

Premedication
-------------

Pre-anaesthetic medication consisted of 5 μg kg^-1^medetomidine and 0.1 mg kg^-1^morphine given by IM injection. Moderate sedation was achieved and an 18 gauge, 45 mm long over-the-needle catheter was inserted aseptically into the left cephalic vein. With the patient sedated, the surgical area was clipped and prepared.

Intraoperative management
-------------------------

Anaesthesia was induced intravenously with 3 mg kg^-1^of propofol, followed by maintenance with isoflurane in 100% oxygen, delivered via a size 11-cuffed endotracheal tube and a small animal circle breathing system. The lungs were mechanically ventilated which was adjusted to maintain end tidal carbon dioxide within the reference range (4.6-6 kPa). Arterial blood pressure was monitored non-invasively, using an oscillometric device placed proximal to the left hock. Body temperature and an electrocardiogram were recorded continuously and a blood gas sample was taken intraoperatively from the lingual artery. The body temperature was maintained with a heated air-warming blanket placed over the caudal half of the body. Isotonic crystalloid fluid was infused at 10 ml kg^-1^hr^-1^through the cephalic cannula.

Before the surgery started, the patient was positioned in left lateral recumbency and meloxicam 0.2 mg kg^-1^was administered intravenously. A balanced anaesthetic technique included isoflurane, with vaporiser settings between 0.8-2% and IV boluses of ketamine (0.5 mg kg^-1^) and fentanyl (2 μg kg^-1^) followed by IV infusions of ketamine^-1^at 10 μg kg-^1^min^-1^and fentanyl at 0.2-0.5 μg kg-^1^min^-1^.

Myotomy of the superficial and deep pectoral muscles exposed a 10 cm × 5 cm mass on the medial aspect of the proximal humerus. The axillary lymph node was grossly enlarged and discoloured. Incisional biopsy of the mass was combined with excisional biopsy of the regional lymph node. Intraoperative cytology confirmed a mesenchymal tumour with benign cytological characteristics and a reactive lymph node. Excision of the mesenchymal tumour was attempted but, as dissection progressed, the median and ulna nerves were involved with the tumour which prevented its complete excision and retention of a functional limb. Amputation of the right thoracic limb was performed.

During the surgical procedure, a total dose of 1.5 mg kg^-1^of bupivacaine was administered. Firstly, perineural injections of 0.25-0.5 ml per site were performed into peripheral nerves encountered during amputation. Perineural injection was not performed if resistance to injection was encountered. Secondly, a wound catheter was sutured into the surgical site with the remainder of the bupivacaine administered after closure of the surgical wound. This \'home-made\' wound catheter was created from a six French nasogastric catheter with multiple punctures made along its length, made with a 28 gauge needle.

Blood loss during surgery was estimated to represent 210 ml of blood or 10-11% of the patient\'s total blood volume \[[@B33]\]. Isotonic crystalloids were replaced with colloids infused at 10 ml kg^-1^administered over one hour to maintain colloid osmotic pressure and provide volume expansion of a longer duration

Postoperative management
------------------------

For recovery from anaesthesia, the dog was placed in left lateral recumbency with the head and shoulders elevated to a sternal position to assist ventilation and to reduce the risk of regurgitation. Oxygen was provided via a nasal catheter at a rate of 1 L min^-1^. Isotonic crystalloids were administered at 5 ml kg^-1^min^-1^. A transdermal fentanyl patch (TDF) delivering fentanyl at 75 μg hr^-1^was placed onto the clipped skin on the left lateral shoulder dorsal to the wound and bandaged in place. A constant rate infusion of ketamine at 2 μg kg^-1^min^-1^and fentanyl at 0.05 μg kg^-1^min^-1^was administered. Bupivacaine at 1 mg kg^-1^was injected into the wound via the catheter in the surgical site every six hours for 24 hours.

Ninety minutes after the end of surgery, the patient was still depressed and tachypnoeic with normal temperature (38.5°C) and a regular heart rate (84 beats/minute). In response to gentle wound palpation, there was a mild head lift and whimper. To assess pain, the short form of the Glasgow Composite Measure Pain score (CMPS-SF) \[[@B42]\] was used and his pain score was graded at eight out of 20. An arterial blood sample was taken from the dorsal metatarsal artery for blood gas analysis confirming respiratory acidosis (Table [1](#T1){ref-type="table"}). Clinical findings indicated hypoventilation secondary to either excessive drug administration or pain and thoracic bracing. The analgesic therapy was changed; the fentanyl infusion was ceased and a loading dose of lidocaine (1 mg kg^-1^over 15 minutes) was administered followed by constant rate infusions of morphine (0.12 mg kg^-1^hr^-1^), lidocaine (1 mg kg^-1^hr^-1^) and ketamine (0.12 mg kg^-1^hr^-1^) (MLK). An additional injection of bupivacaine (0.5 mg kg^-1^) was administered into the wound catheter.

###### 

Arterial and venous blood gas analysis immediately post-surgery, three hours post-surgery and 18 hours after surgery

  Parameters measured    Immediately after surgery (arterial blood)   **Reference range arterial blood for dogs**\[[@B13]\]   Three hours after surgery (venous blood)   **Reference range venous blood for dogs**\[[@B21]\]   Eighteen hours after surgery (arterial blood)   **Reference range arterial blood for dogs**\[[@B13]\]
  ---------------------- -------------------------------------------- ------------------------------------------------------- ------------------------------------------ ----------------------------------------------------- ----------------------------------------------- -------------------------------------------------------
  pH                     7.203                                        7.38 - 7.44                                             7.374                                      7.33 - 7.38                                           7.383                                           7.38 - 7.435
  PCO2 (kPa)             8.65                                         4.51 - 5.31                                             5.04                                       5.03 - 6.20                                           5.53                                            4.51 - 5.31
  PO2 (kPa)              15.89                                        11.5 - 13.03                                            12.83                                      6.05 - 8.61                                           12.93                                           11.5 - 13.03
  HCO3-std (mmol/l)      21.3                                         20.5 - 23.9                                             21.7                                       20.9 - 23.5                                           23.8                                            20.5 - 23.9
  Base excess (mmol/l)   -3.9                                         -2.6 - 0.4                                              -3.3                                       -3.8 - -0.4                                           -0.9                                            -2.6 - 0.4
  Interpretation         Primary respiratory acidosis                 Within acceptable limits (with mild hyperoxaemia)       Within acceptable limits                                                                                                                         

Four hours after the end of anaesthesia a venous blood gas showed resolution of the previous blood gas abnormalities (Table [1](#T1){ref-type="table"}). Nasal oxygen therapy was ceased. Eight hours after surgery the patient appeared comfortable, was wagging his tail and able to stand. He could walk, although he was unsteady. The following morning he was walking without difficulty, urinating, defecating, eating and drinking. The MLK infusion was stopped and the IV cannula removed. An arterial blood gas sample was within reference limits (Table [1](#T1){ref-type="table"}). A CMPS-SF was assessed as one out of 24.

Meloxicam at 0.1 mg kg^-1^per os was administered daily for seven days and cold packing applied twice daily over the surgical site for two days. The wound catheter was removed after 24 hours, but the TDF remained in place for three days. During this period the dog was boisterous and affectionate, showing no aggression towards handlers. The patient was discharged to the owners on the third day after surgery. A diagnosis of a poorly differentiated sarcoma was made histologically.

Discussion
==========

Pain assessment in the dog
--------------------------

Pain assessment is performed regularly in many veterinary practices and yet pain is difficult to quantify reliably \[[@B10],[@B39]\]. The experience and behavioural manifestations of pain are unique to each individual and disease, and the inability of animals to communicate is frustrating for veterinary professionals. There is great variation between different patients, not only due to species-specific pain behaviours, but also because many behaviours are not specific for pain. Pain may also occur without any associated or measurable behaviours; for this reason it has been suggested that only observers who are familiar with the individual animal should perform assessment of pain \[[@B20]\].

Objective measurement of pain has been attempted by identifying physiological factors, such as heart rate and blood pressure, which are known to be affected by pain. Unfortunately there appears to be poor correlation between physical parameters and pain \[[@B6],[@B17]\]. This incongruence is likely due to other influences on these physiological parameters such as fear, anxiety or physiological responses to drugs or disease. Testing responses to noxious stimuli mediated via spinal reflexes has been used to assess analgesic efficacy but may not test the appropriate pathways for postoperative pain \[[@B36]\]. Clinical scoring systems for assessing the severity and intensity of pain in animals have been developed. Subjective scales which grade pain according to single parameters such as the degree of pain intensity are not sensitive to all the dimensions of pain and can have significant inter-observer variation \[[@B18],[@B19],[@B10]\]. They may also lack clear definitions, clinical validation and described intervention criteria for treatment to be initiated \[[@B19]\]. However, scales such as the simple descriptive scale \[[@B18]\], the visual analogue score \[[@B29],[@B9]\] and the numerical rating score \[[@B45],[@B1]\] have all been used to determine the degrees of pain shown by animals in clinical studies Pain is known to modify spontaneous and interactive behaviour, \[[@B34]\] therefore several pain scales have been developed which use a composite score based on a multivariate numerical rating scale of pain-associated behaviours \[[@B14],[@B8],[@B19]\]. Current protocol at the University Veterinary Hospital is to use the CMPS-SF to aid in the assessment of postoperative pain in dogs. This dog-specific behavioural-based pain scale, which was created by identifying the \'language of pain\' in dogs and then placing clearly defined behavioural descriptors into validated and weighted categories. A scaling model was developed to create a continuous scale \[[@B34]\] and intervention scores for pain relief are recommended \[[@B11],[@B42]\]. This accessible tool can be downloaded from the internet \[[@B11]\], however more work is required to test the scales validity under clinical conditions. Pain scores should be used as adjuncts to support clinical judgement; a low pain score should not prevent test boluses of analgesic agents being given if pain is suspected by the veterinarian responsible for the case. The CMPS-SF was used to assist in decisions regarding analgesia in this dog.

Preoperative pain management
----------------------------

Preoperative analgesic agents are mainly given to provide pre-emptive analgesia. Whilst true pre-emptive analgesia was not possible due to pre-existing pain in the patient of this report, preventing surgical pain and reduction of the amount of hypersensitisation (due to the chronicity of the noxious stimuli) was desirable. Medetomidine, morphine and meloxicam were administered to this patient prior to surgery. A multimodal combination was chosen to produce synergy and an additive analgesic effect whilst reducing the individual drug doses \[[@B25],[@B9],[@B43]\]. Larger doses of a single analgesic drug, such as morphine, can inhibit normal physiological functions such as gastrointestinal motility and function and produce undesirable effects including excessive sedation or vomiting \[[@B25],[@B43]\].

This patient received a preoperative injection and postoperative oral course of meloxicam, a non-steroidal anti-inflammatory drug (NSAID). The advantage of NSAIDs is that they provide continued systemic analgesia, reduce inflammation and can be continued for long periods. They are not controlled drugs and can be administered by the owners. NSAIDs are contraindicated in a number of conditions \[[@B7]\] but were not contra-indicated in the dog of this report.

Intraoperative pain management
------------------------------

Management of noxious stimuli during operations has many advantages including producing a balanced and stable anaesthetic and reducing the adverse responses to surgery, e.g. tachycardia, hypertension, tachypnoea and the neurohormonal stress responses.

Many analgesic drugs will allow reduction of the dose of the volatile inhalant agents, either by providing hypnotic or analgesic actions. At surgical depths of anaesthesia, volatile agents cause dose-dependent cardiorespiratory depression and have poor analgesic properties \[[@B50]\]. Use of adjunctive agents to reduce the dose of inhalant agents often improves cardiorespiratory function \[[@B35],[@B49]\]. IV infusions of fentanyl and ketamine were administered intraoperatively in this patient. Administering drugs as infusions has the added advantages of reducing variability in the plasma concentrations of the drug and decreasing the frequency of patient handling.

Ketamine is particularly indicated as an adjunctive agent in the control of neuropathic and chronic pain due to its antagonism of the excitatory neurotransmitter glutamate at the NMDA-receptors, which are involved with hypersensitisation and \'wind-up\' \[[@B56],[@B38]\]. Ketamine infusions in dogs can reduce the minimum alveolar concentration of isoflurane by 29% (10 μg kg^-1^min^-1^) \[[@B35]\] or with high doses of ketamine, by up to 95% \[[@B48]\].

Fentanyl is a mu-opioid receptor agonist, which has inhalant agent-sparing properties; in dogs undergoing unilateral mastectomy, IV fentanyl infusion (0.5 μg kg^-1^min^-1^) reduced the requirement for isoflurane by up to 66% \[[@B49]\]. Fentanyl causes hypoventilation, often necessitating intermittent positive pressure ventilation (IPPV); this was necessary in our patient. Opioids have minimal effects on cardiac output and arterial blood pressure at analgesic doses; vagally-mediated bradycardia does occur, but responds to anticholinergic treatment if required. Fentanyl has a significant context-sensitive half-time and in practice this means that after longer infusions, such as the three hour infusion in the dog of this report, clinical effects including respiratory depression may persist after termination of the infusion \[[@B28]\].

This patient received bupivacaine by perineural injection of the transected nerves during amputation and by wound infiltration postoperatively. An alternative route of administration is by paravertebral injection around the spinal nerves of C6-8 and T1 \[[@B16]\]; this technique can lead to phrenic nerve blockade and accidental intrapleural injections. Bupivacaine is an aminoamide local anaesthetic drug which has an onset of 20-30 minutes and duration of four to six hours after administration by infiltration, peripheral nerve blockade or epidural/dural routes \[[@B30]\]. Local anaesthetic drugs prevent nerve transmission and may therefore prevent the development of central hypersensitisation and phantom limb pain postoperatively \[[@B23],[@B43]\]. Neuroma formation following infiltration of the nerve trunk is uncommon in dogs \[[@B54]\]; however intraneural injections can lead to neurologic complications \[[@B2]\], particularly when high injection pressures develop during injection \[[@B22]\].

Postoperative pain management
-----------------------------

Treatment of postoperative pain is likely to convey many advantages, including quicker recovery from anaesthesia, rapid return to normal functions and prevention of behavioural changes, self-mutilation, gastrointestinal dysfunction and a systemic catabolic state which may impair wound healing \[[@B12],[@B40]\]. Continued postoperative analgesia is also important to prevent development of hypersensitisation which can result from ongoing peripheral inflammation and noxious input \[[@B56],[@B5]\]. Due to the chronic and severe nature of the pain in our patient, it was decided to continue IV infusions of fentanyl and ketamine. There is limited information about the postoperative infusion rate of analgesic drugs, with different rates being suggested by different authors \[[@B53],[@B47],[@B51],[@B12],[@B40]\]. One study of thoracic limb amputations in dogs assessed an intraoperative infusion of saline versus ketamine (10 μg kg^-1^min^-1^IV followed by postoperative ketamine IV infusion for 18 hours at a lower dose of 2 μg kg^-1^min^-1^). Both groups of patients were given infusions of fentanyl for 18 hours postoperatively at 1-5 μg kg^-1^hour^-1^. This study indicated better pain control and increased patient activity when the ketamine and fentanyl infusions were administered together given over a fentanyl infusion alone \[[@B53]\]. Another study of bitches undergoing mastectomy revealed improved feeding behaviour in patients receiving ketamine IV infusions (10 μg kg^-1^min^-1^) but no difference in opioid requirements between treatment and control groups \[[@B46]\]. TDF patches which are often used in dogs for postoperative analgesic therapy \[[@B15]\] can reduce the requirement for repeated injections. Hence, this technique was an advantage in this aggressive patient. Evidence suggests that TDF patches are adequate as a sole means of postoperative analgesia in a variety of orthopaedic procedures \[[@B26],[@B44],[@B27]\]; however plasma fentanyl concentrations and analgesic efficacy are inconveniently variable in dogs. Multimodal analgesic therapy and ongoing pain assessment is therefore prudent.

Clinical trials assessing postoperative constant rate infusions of local anaesthetics via local delivery systems have shown similar degrees of analgesia between lidocaine and IV morphine infusions \[[@B55]\]. However, no additional analgesia was achieved from IM morphine and locally infused bupivacaine administered together \[[@B41]\]. We elected to utilise this method of delivery for administration of bupivacaine since infiltration of local anaesthetics is a well-established technique for analgesia and local anaesthetics are not associated with any increased risk of complications associated with wound healing \[[@B4],[@B41],[@B55]\].

In our patient, tachypnoea and significant respiratory acidosis was observed postoperatively. These findings were thought to be indicative of either pain or excessive opioid administration. We elected to stop the fentanyl infusion, since it can cause respiratory depression. A decision was taken to cease the fentanyl IV infusion, since it can cause respiratory depression (although the TDF remained in place since it was unlikely to yet be effective) and supplement analgesia by using IV infusions of morphine, lidocaine and ketamine (MLK) and administering additional bupivacaine into the wound catheter. Our aim was to resolve the respiratory depression by either improving analgesia, thereby reducing the patient bracing his thorax against movement, and/or by ceasing IV fentanyl infusion which can cause hypoventilation.

An MLK infusion was chosen as it is commonly used in our hospital for treatment of patients with severe postoperative pain. We have not observed significant respiratory depression in our patients. The postoperative use of MLK has not been validated and only postoperative infusions of morphine \[[@B31]\] or ketamine with fentanyl have been assessed in dogs \[[@B53]\]. Postoperative morphine infusions have been compared to IM morphine injections every four hours in dogs, which had undergone exploratory laparotomy, and the two routes of administration provided similar degrees of analgesia and similar cardiorespiratory effects \[[@B31]\]. Side effects which have been observed after using MLK infusion in our patients include bradycardia, altered mentation, dysphoria and panting. Active metabolites of morphine and ketamine are produced \[[@B52]\], which may accumulate over time, making these infusions less suitable for administering over very long periods. The side effects observed in other patients were not seen in this patient after MLK infusion. After alteration of the analgesic strategy, the patient showed a lower pain score and resolution of the respiratory acidosis. The use of alternative perioperative analgesics such as tramadol, gabapentin and amantadine has been reported \[[@B28]\]. All three are oral medications which can be prescribed for home use and may be indicated in chronic pain states. However, in Ireland these drugs require specific import and usage licenses from the Irish government. Therefore, as analgesia was deemed to be well controlled in this case, the agents mentioned were not considered.

Painful sensations occur in 50-80% of human amputees and can persist for years following amputation, \[[@B43]\]. The prevalence of long-term phantom limb pain in dogs is not known and reports of self-mutilation and behavioural changes post-nerve transection have only been made in rats \[[@B24]\] and one cat \[[@B37]\]. There was no report in this dog of persisting clinical signs which would indicate phantom limb pain.

Conclusion
==========

In this dog, whose thoracic limb was amputated due to a tumour of the brachial plexus, a combination of multimodal and pre-emptive analgesic therapies were used and the patient was assessed using the short form of the Glasgow composite measure pain score. There was a positive response to the analgesic regimen used with a quick return to normal activity and walking after amputation. The patient did not suffer further complications relating to the amputation.
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